Assessment and Management of Insomnia

JAMA

Volumn 289, Issue 19, 2003, Pages 2475-2479

  Schenck, Carlos H ^a,c   Mahowald, Mark W ^a   Sack, Robert L ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; ZALEPLON; ZOLPIDEM;

ALCOHOL CONSUMPTION; ANXIETY; BEHAVIOR THERAPY; CIRCADIAN RHYTHM; COGNITIVE THERAPY; DEPRESSION; DRUG ABUSE; HUMAN; INSOMNIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP DISORDER; SLEEP PATTERN; TREATMENT PLANNING; COST OF ILLNESS;

CIRCADIAN RHYTHM; COST OF ILLNESS; HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0038651275     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.19.2475     Document Type: Review

References (31)

1. Diagnostic Classification Steering Committee. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, Minn: American Sleep Disorders Association; 1990.
2. Nowell PD, Buysse DJ. Treatment of insomnia in patients with mood disorders. Depress Anxiety. 2001;14:7-18.
3. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97-111.
4. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37:9-15.
5. Moul DE, Nofzinger EA, Pilkonis PA, et al. Symptom reports in severe chronic insomnia. Sleep. 2002;25:553-563.
6. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-1439.
7. Martinez-Gonzalez D, Obermeyer WH, Benca RM. Comorbidity of insomnia with medical and psychiatric disorders. Prim Psychiatry. 2002;9:37-49.
8. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163:205-209.
9. Richardson GS, Doghramji K, Ancoli-Israel S, et al. Practical management of insomnia in primary care: an overview for the busy practitioner. Sleep. 2000;23 (suppl 1):S1-S48.
10. Zorick FJ, Walsh JK. Evaluation and management of insomnia: an overview. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, Pa: WB Saunders Co; 2000:615-623.
11. Sateia MJ. Epidemiology, consequences, and evaluation of insomnia. In: Lee-Chiong TL Jr, Sateia MJ, Carskadon MA, eds. Sleep Medicine. Philadelphia, Pa: Hanley & Belfus Inc; 2002:151-160.
12. Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 2001;39:45-60.
13. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
14. Drewes AM, Arendt-Nielsen L. Pain and sleep in medical diseases: interactions and treatment possibilities: a review. Sleep Res Online. 2001;4:67-76.
15. Mahowald ML, Mahowald MW. Nighttime sleep and daytime functioning (sleepiness and fatigue) in well-defined chronic rheumatic diseases. Sleep Med. 2000;1:179-193.
16. Senior BA, Khan M, Schwimmer C, Rosenthal L, Benninger M. Gastroesophageal reflux and obstructive sleep apnea. Laryngoscope. 2001;111:2144-2146.
17. Mahowald MW, Schenck CH. Parasomnias including the restless legs syndrome. Clin Chest Med. 1998;19:183-202.
18. Schenck CH, Mahowald MW. Parasomnias: managing bizarre sleep-related behavior disorders. Post-grad Med. 2000;107:145-156.
19. Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord. 2001;16:1105-1109.
20. Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100:333-337.
21. Hajak G, Bandelow B. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases. Int Clin Psychopharmacol. 1998;13:157-167.
22. Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59:865-885.
23. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285:1856-1864.
24. Marcus DM, Grollman AP. Botanical medicines: the need for new regulations. N Engl J Med. 2002;347:2073-2076.
25. Wing YK. Herbal treatment of insomnia. Hong Kong Med J. 2001;7:392-402.
26. Ziegler G, Ploch M, Miettinen-Baumann A, Collet W. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia: a randomized, double-blind, comparative clinical study. Eur J Med Res. 2002;7:480-486.
27. Dagan Y. Circadian rhythm sleep disorders (CRSD). Sleep Med Rev. 2002;6:45-55.
28. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97-110.
29. Terman M, Terman SJ. Light therapy. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, Pa: WB Saunders Co; 2000:1258-1274.
30. Sack RL, Lewy AJ, Hughes RJ. Guidelines for prescribing melatonin for sleep and circadian rhythm disorders. Ann Med. 1998;30:115-121.
31. Burgess HJ, Sharkey KM, Eastman CI. Bright light, dark and melatonin can promote circadian adaptation in night shift workers. Sleep Med Rev. 2002;6:407-420.